This developer of magnetic resonance imaging (MRI) compatible products has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price climb is encouraging though, so make sure to keep a close watch on this firm in the near future.
IRadimed currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Stocks worth considering in the medical instruments industry are RTI Surgical Inc. (RTIX), Bacterin International Holdings, Inc. (BONE) and Echo Therapeutics, Inc. (ECTE). While RTI Surgical sports a Zacks Rank #1 (Strong Buy), Bacterin International and Echo Therapeutics carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment